Went public 7/28/2000 at $18 per share
Filing Range: 6 mil. shares @ $15 to $17
Shares Outstanding: 21 mil. shares
Underwriters: ING Barings/Prudential Vector Healthcare/
Company Counsel: Morgan Lewis & Bockius
Manager Counsel: Winthrop Stimson Putnam & Roberts
Auditor: Ernst & Young LLP
Develops receptor-based biochemichal assays that are used to discover small molecule therapeutics. “CART” technology allows cell-surface receptors to be screened against chemical libraries. CART technology is geared toward the G protein-coupled receptor class and identifies compounds having improved therapeutic utility at known receptors.
MPM Asset Management LLC
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 01/29/1999 8 Later Stage 17000.0
2 04/27/2000 2 Expansion 9659.0
(Data in $ millions)
Total Revenues: $0.1
Net Income: -10.2